Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | BNTX | INCY | ||
| Company | Genmab A/S ADR | Biontech Se ADR | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 32.06 | 96.41 | 101.00 | ||
| High | 32.13 | 96.69 | 103.68 | ||
| Low | 31.50 | 95.21 | 98.36 | ||
| Latest | 31.74 | 96.25 | 102.52 | ||
| Change | -0.28 | +0.25 | +2.06 | ||
| % Change | -0.87% | +0.26% | +2.05% | ||
| Volume | 781,600 | 1,270,200 | 2,357,000 | ||
| 20-Day Average Volume | 1,417,530 | 1,332,610 | 2,034,815 | ||
| Previous Close | 32.02 | 96.00 | 100.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.79 | 100.96 | 104.05 | ||
| 20-Day Raw Stochastic | 81.77% | 11.60% | 38.11% | ||
| 20-Day Relative Strength | 58.96 | 41.75 | 57.59 | ||
| Weighted Alpha | +57.87 | -20.65 | +51.26 | ||
| Today's Opinion | 100% Buy | 88% Sell | 88% Buy | ||
| Previous Opinion | 88% Buy | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 48% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.92% since 11/28/25 | -6.69% since 11/28/25 | -1.86% since 11/28/25 | ||
| Low | 31.32 on 12/01/25 | 95.21 on 12/05/25 | 98.36 on 12/05/25 | ||
| High | 32.47 on 12/01/25 | 101.84 on 12/01/25 | 103.89 on 12/01/25 | ||
| 1-Month | |||||
| %Chg | +8.74% since 11/05/25 | -6.94% since 11/05/25 | -3.01% since 11/05/25 | ||
| Low | 28.15 on 11/06/25 | 94.00 on 11/24/25 | 98.36 on 12/05/25 | ||
| High | 32.48 on 11/28/25 | 113.39 on 11/12/25 | 109.28 on 11/12/25 | ||
| 3-Month | |||||
| %Chg | +15.25% since 09/05/25 | -14.41% since 09/05/25 | +18.33% since 09/05/25 | ||
| Low | 27.14 on 09/08/25 | 90.12 on 09/12/25 | 81.09 on 09/25/25 | ||
| High | 33.65 on 10/16/25 | 113.39 on 11/12/25 | 109.28 on 11/12/25 | ||
| 6-Month | |||||
| %Chg | +45.53% since 06/05/25 | -12.62% since 06/05/25 | +52.47% since 06/05/25 | ||
| Low | 20.23 on 07/03/25 | 90.12 on 09/12/25 | 66.74 on 06/23/25 | ||
| High | 33.65 on 10/16/25 | 115.54 on 07/25/25 | 109.28 on 11/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,389,268 | 21,673,768 | 20,127,032 | ||
| Shares Outstanding, K | 642,384 | 225,182 | 196,323 | ||
| Annual Sales | 3,121,270,000 | 2,976,970,000 | 4,241,220,000 | ||
| Annual Net Income | 1,137,380,000 | -719,920,000 | 32,610,000 | ||
| Last Quarter Sales | 1,022,000,000 | 1,775,440,000 | 1,365,980,000 | ||
| Last Quarter Net Income | 401,000,000 | -33,550,000 | 424,170,000 | ||
| 60-Month Beta | 0.90 | 1.30 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.65 on 11/06/25 | -0.14 on 11/03/25 | 2.26 on 10/28/25 | ||
| Latest Earnings Date | 11/06/25 | 11/03/25 | 10/28/25 | ||
| Most Recent Dividend | N/A | 3.084 on 06/02/22 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/02/22 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.47 | 0.00 | 18.88 | ||